Alok Dalal
Stock Analyst at Jefferies
(3.75)
# 2,066
Out of 5,125 analysts
96
Total ratings
60.3%
Success rate
8%
Average return
Main Sectors:
Stocks Rated by Alok Dalal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: CIPLA Cipla Limited | Upgraded: Hold | ₹1,170 → ₹1,270 | ₹1,404 | -9.53% | 9 | Oct 29, 2026 | |
| NSE: MANKIND Mankind Pharma Limited | Reiterated: Buy | ₹3,220 → ₹2,900 | ₹2,668 | +8.68% | 8 | Oct 29, 2026 | |
| NSE: DRREDDY Dr. Reddy's Laboratories Limited | Upgraded: Hold | ₹1,100 → ₹1,320 | ₹1,385 | -4.69% | 3 | Oct 25, 2026 | |
| RDY Dr. Reddy's Laboratories | Upgraded: Hold | $12 → $14 | $15.05 | -6.55% | 5 | Oct 25, 2026 | |
| NSE: ALKEM Alkem Laboratories Limited | Reiterated: Buy | ₹6,500 → ₹6,400 | ₹5,399 | +18.55% | 6 | Aug 20, 2026 | |
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Reiterated: Buy | ₹9,700 → ₹10,350 | ₹8,550 | +21.06% | 5 | Aug 17, 2026 | |
| NSE: EMCURE Emcure Pharmaceuticals Limited | Reiterated: Buy | ₹2,100 → ₹2,320 | ₹2,215 | +4.74% | 9 | Aug 11, 2026 | |
| NSE: ENTERO Entero Healthcare Solutions Limited | Reiterated: Buy | ₹1,500 → ₹1,800 | ₹2,089 | -13.83% | 7 | Aug 11, 2026 | |
| NSE: GLAND Gland Pharma Limited | Upgraded: Buy | ₹2,080 → ₹3,350 | ₹3,285 | +1.98% | 5 | Aug 11, 2026 | |
| NSE: SAILIFE Sai Life Sciences Limited | Reiterated: Buy | ₹1,270 → ₹1,610 | ₹1,836 | -12.31% | 5 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | ₹300.00 → ₹350.00 | ₹443.50 | -21.08% | 2 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,500 → ₹1,660 | ₹1,429 | +16.14% | 6 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹1,100 → ₹1,700 | ₹2,454 | -30.73% | 4 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,380 → ₹1,500 | ₹915.00 | n/a | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹2,400 → ₹2,250 | ₹2,025 | n/a | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹1,620 → ₹1,700 | ₹598.40 | n/a | 3 | May 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,350 → ₹1,150 | ₹1,216 | n/a | 3 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹6,280 → ₹6,200 | ₹11,566 | n/a | 2 | May 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹260.00 | ₹245.30 | n/a | 1 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹2,850 → ₹3,140 | ₹3,346 | n/a | 2 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹890.00 → ₹650.00 | ₹436.00 | n/a | 2 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹860.00 → ₹850.00 | ₹774.55 | n/a | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹2,260 → ₹2,265 | ₹1,905 | n/a | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | ₹400.00 | ₹368.50 | n/a | 1 | Jan 6, 2025 |
Cipla Limited
Oct 29, 2026
Upgraded: Hold
Price Target: ₹1,170 → ₹1,270
Current: ₹1,404
Upside: -9.53%
Mankind Pharma Limited
Oct 29, 2026
Reiterated: Buy
Price Target: ₹3,220 → ₹2,900
Current: ₹2,668
Upside: +8.68%
Dr. Reddy's Laboratories Limited
Oct 25, 2026
Upgraded: Hold
Price Target: ₹1,100 → ₹1,320
Current: ₹1,385
Upside: -4.69%
Dr. Reddy's Laboratories
Oct 25, 2026
Upgraded: Hold
Price Target: $12 → $14
Current: $15.05
Upside: -6.55%
Alkem Laboratories Limited
Aug 20, 2026
Reiterated: Buy
Price Target: ₹6,500 → ₹6,400
Current: ₹5,399
Upside: +18.55%
Apollo Hospitals Enterprise Limited
Aug 17, 2026
Reiterated: Buy
Price Target: ₹9,700 → ₹10,350
Current: ₹8,550
Upside: +21.06%
Emcure Pharmaceuticals Limited
Aug 11, 2026
Reiterated: Buy
Price Target: ₹2,100 → ₹2,320
Current: ₹2,215
Upside: +4.74%
Entero Healthcare Solutions Limited
Aug 11, 2026
Reiterated: Buy
Price Target: ₹1,500 → ₹1,800
Current: ₹2,089
Upside: -13.83%
Gland Pharma Limited
Aug 11, 2026
Upgraded: Buy
Price Target: ₹2,080 → ₹3,350
Current: ₹3,285
Upside: +1.98%
Sai Life Sciences Limited
Aug 11, 2026
Reiterated: Buy
Price Target: ₹1,270 → ₹1,610
Current: ₹1,836
Upside: -12.31%
Aug 6, 2026
Reiterated: Sell
Price Target: ₹300.00 → ₹350.00
Current: ₹443.50
Upside: -21.08%
Aug 4, 2026
Reiterated: Buy
Price Target: ₹1,500 → ₹1,660
Current: ₹1,429
Upside: +16.14%
Jul 28, 2026
Reiterated: Hold
Price Target: ₹1,100 → ₹1,700
Current: ₹2,454
Upside: -30.73%
Aug 14, 2025
Reiterated: Buy
Price Target: ₹1,380 → ₹1,500
Current: ₹915.00
Upside: n/a
Aug 7, 2025
Upgraded: Buy
Price Target: ₹2,400 → ₹2,250
Current: ₹2,025
Upside: n/a
May 31, 2025
Reiterated: Hold
Price Target: ₹1,620 → ₹1,700
Current: ₹598.40
Upside: n/a
May 21, 2025
Reiterated: Buy
Price Target: ₹1,350 → ₹1,150
Current: ₹1,216
Upside: n/a
May 18, 2025
Reiterated: Hold
Price Target: ₹6,280 → ₹6,200
Current: ₹11,566
Upside: n/a
May 15, 2025
Reiterated: Buy
Price Target: ₹260.00
Current: ₹245.30
Upside: n/a
Apr 30, 2025
Reiterated: Buy
Price Target: ₹2,850 → ₹3,140
Current: ₹3,346
Upside: n/a
Apr 25, 2025
Reiterated: Hold
Price Target: ₹890.00 → ₹650.00
Current: ₹436.00
Upside: n/a
Feb 10, 2025
Reiterated: Buy
Price Target: ₹860.00 → ₹850.00
Current: ₹774.55
Upside: n/a
Jan 31, 2025
Reiterated: Buy
Price Target: ₹2,260 → ₹2,265
Current: ₹1,905
Upside: n/a
Jan 6, 2025
Upgraded: Hold
Price Target: ₹400.00
Current: ₹368.50
Upside: n/a